Related Experiment Video
Updated: Mar 24, 2026
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Increased expression of SMAD5-AS1 in glioma is associated with patient prognosis and immunity
Junqi Ren1, Xujun Shan2, Hongrong Wu2
1Department of Pathology, The Second Affiliated Hospital of Guangdong Medical University Zhanjiang 524001, Guangdong, China.
Abstract:
The aim of this study was to examine the expression profile, clinical significance, and potential diagnostic/prognostic value of the long non-coding RNA (lncRNA) SMAD5-AS1 in glioma.
Methods:
Expression of SMAD5-AS1 and its associations with survival were analyzed in patients with lower-grade glioma (LGG) and glioblastoma (GBM) using GEPIA2, R, UALCAN, and TIMER3 platforms.
Results:
SMAD5-AS1 was significantly upregulated in multiple cancers, particularly gliomas (LGG and GBM; P < 0.05), demonstrating strong diagnostic performance for GBM (AUC = 0.87) and moderate performance for LGG (AUC = 0.71). In LGG, high SMAD5-AS1 expression was associated with poorer overall survival (HR = 25.53; P < 0.001) and enrichment in higher-grade tumors and astrocytic subtypes (P < 0.01), suggesting a link to tumor aggressiveness. Furthermore, SMAD5-AS1 expression was negatively correlated with infiltration by immunosuppressive cells, implicating a role in modulating the tumor immune microenvironment.
Conclusion:
SMAD5-AS1 represents a promising diagnostic and prognostic biomarker in glioma, with elevated expression linked to increased tumor aggressiveness, immunosuppression, and adverse patient outcomes.
Related Concept Videos
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
01:27Tumor Immunotherapy